News
DGAP-News: HAEMATO AG - preliminary figures for the 2021 financial year: Renewed increase in sales and strong rise in earnings after disproportionate growth of the new Lifestyle and Aesthetics business unit
Extreme flood events once again drive high losses in 2021, yet 75% of flood risks remain uninsured, Swiss Re Institute reveals
DGAP-News: PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD
Nordea Bank Abp: Flagging notification
Nordea Bank Abp: Transaction in Own Shares
DGAP-News: GRAMMER AG closes Financial Year 2021 with significantly higher revenue and earnings
RM plc: Director/PDMR Performance Share Plan Awards
DGAP-News: TAKKT AG: TAKKT to shape the future worlds of work and increase sales to EUR two billion by 2025
DGAP-News: PAION AG REPORTS ON FISCAL YEAR 2021
DGAP-News: ENCAVIS AG publishes first Sustainability Report in accordance with new GRI standard
DGAP-News: STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR
indie Semiconductor Announces Retirement of Bill Woodward and Appointment of Diane Biagianti to Its Board of Directors
indie Semiconductor (Nasdaq: INDI), an Autotech solutions innovator, today announced that Bill Woodward has retired and Diane Biagianti has been appointed to its board of directors. Biagianti
McGrath RentCorp Sets First Quarter 2022 Financial Results Date and Time
McGrath RentCorp (NASDAQ: MGRC) (the “Company”), a diversified business-to-business rental company, today announced plans to release financial results for its first quarter ending March 31, 2022
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth
Alcoa Schedules First Quarter 2022 Earnings Release and Conference Call
Alcoa Corporation plans to announce its first quarter 2022 financial results on Wednesday, April 20, 2022 after the close of trading on the New York Stock Exchange.
The press release with
Fluor Joint Venture Receives Final Notice-to-Proceed on Interstate 35E Phase 2 Project in Dallas
Fluor Corporation (NYSE: FLR) announced today that Lone Star Constructors, its joint venture with Austin Bridge & Road, has been granted final notice-to-proceed by the Texas Department of
UDR Announces Public Offering of 7,000,000 Shares of Common Stock
UDR, Inc. (the “Company”) (NYSE: UDR), announced today that it is commencing an underwritten public offering of 7,000,000 shares of common stock in connection with the forward sale agreements
Walmart Announces 2022 Annual Shareholders’ Meeting Date
Walmart Inc. (NYSE: WMT) today announced that its Annual Shareholders’ Meeting will be held on Wednesday, June 1, 2022. The meeting will be held in a virtual-only format and will begin at 10:30
ABIONYX Pharma Receives FDA Orphan Drug Designation (ODD) for CER-001 for the Treatment of LCAT Deficiency Presenting as Kidney Dysfunction and/or Ophthalmologic Disease
Regulatory News:
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for
AIG Announces Proposed Senior Notes Offering by Corebridge Financial, Inc.
American International Group, Inc. (NYSE: AIG) today announced that its majority-owned subsidiary, Corebridge Financial, Inc., intends to offer senior unsecured notes (the “Notes”) in connection
Keysight Selected by VTT to Support Open Testing and Integration Facility in Finland
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
DGAP-News: ENCAVIS AG shows significant growth in fiscal 2021 and forecasts an ongoing strong growth for 2022e
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use of their COVID-19 vaccine to include a second